☆ 4.7 Article

TLR8 agonist partially improves IFN-γ deficiency of NK cells in chronic hepatitis B through the synergy of monocytes

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Related references

Note: Only part of the references are listed.

Review Gastroenterology & Hepatology

Getting to HBV cure: The promising paths forward

Scott Fung et al.

Summary: Chronic HBV infection is a global health burden, and achieving a cure remains challenging due to the persistence of cccDNA, HBV-DNA integration, and impaired immune response. Current therapies include DAAs and immunomodulators, but there are still many obstacles to overcome for a complete cure of HBV.

HEPATOLOGY (2022)

Add to Collection

Article Oncology

Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16- subset

Irene Veneziani et al.

Summary: The study suggests that TLR8 in NK cells may serve as a potential target for immunotherapy in patients with cancer.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Add to Collection

Article Immunology

Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg

Xiaoan Yang et al.

Summary: This study aimed to investigate whether interferon-experienced patients could achieve the same HBsAg clearance and seroconversion rates as interferon-naive patients, and to clarify the associated factors and cut-offs. The results showed satisfactory clinical cure of interferon add-on therapy for interferon-experienced patients with low HBsAg. Age, baseline HBsAg, and week 12 HBsAg were negatively correlated with week 48 HBsAg clearance and seroconversion. Interferon-experienced patients with low HBsAg were suggested with interferon add-on therapy for achieving clinical cure.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Immunology

Immunobiology and pathogenesis of hepatitis B virus infection

Matteo Iannacone et al.

Summary: HBV is a hepatotropic virus that can cause persistent infection and serious liver diseases. Immune responses, particularly CD8(+) T cells, play a crucial role in viral clearance and liver pathology.

NATURE REVIEWS IMMUNOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B

Stephane Daffis et al.

Summary: GS-9688 treatment in woodchucks with WHV infection showed significant antiviral efficacy, with a >5 log(10) reduction in viral load and sustained response even after treatment cessation. The treatment also resulted in reduced intrahepatic WHV RNA and DNA levels, and enhanced immune responses in woodchucks.

HEPATOLOGY (2021)

Add to Collection

Article Immunology

Entecavir Plus Pegylated Interferon and Sequential Hepatitis B Virus Vaccination Increases Hepatitis B Surface Antigen Seroclearance: A Randomized Controlled Proof-of-Concept Study

Jeong-Hoon Lee et al.

Summary: This study found that adding pegylated interferon alfa-2a treatment to chronic hepatitis B patients treated with entecavir, followed by sequential HBV vaccination under an intensified schedule, significantly increases the chance of HBsAg seroclearance compared to entecavir alone.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Gastroenterology & Hepatology

Human Hepatitis B Virus Negatively Impacts the Protective Immune Crosstalk Between Natural Killer and Dendritic Cells

Claudia De Pasquale et al.

Summary: The study revealed that HBV infection can affect the ability of DCs to support NK cell functions, leading to disrupted NK-DC interplay and significantly impairing the antiviral immune response in patients with CHB.

HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Therapeutic Potential of TLR8 Agonist GS-9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators

Oliver E. Amin et al.

Summary: GS-9688 activates immune cell subsets and induces the production of immunomodulatory mediators in healthy controls and CHB patients. It boosts antiviral effector functions by activating HBV-specific CD8(+) T cells, CD4(+) follicular helper T cells, NK cells, and mucosal-associated invariant T cells. Additionally, GS-9688 modulates immunoregulatory subsets, potentially optimizing its antiviral efficacy.

HEPATOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview

Mohammad Enamul Hoque Kayesh et al.

Summary: Chronic hepatitis B virus (HBV) infection is a major global health problem, and the link between Toll-like receptors (TLRs) and chronic HBV infection is being increasingly recognized. TLR agonists have the potential to enhance the host immune response against HBV infection and improve CHB treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Gastroenterology & Hepatology

Safety, Pharmacokinetics, and Pharmacodynamics of the Oral TLR8 Agonist Selgantolimod in Chronic Hepatitis B

Edward J. Gane et al.

Summary: Selgantolimod was found to be safe and well-tolerated in patients with chronic hepatitis B (CHB), inducing cytokine responses and antiviral immunity. Although some patients experienced adverse events and laboratory abnormalities, they were mild or moderate in severity. Further studies with longer treatment durations are needed to assess efficacy.

HEPATOLOGY (2021)

Add to Collection

Article Immunology

NK Cell-Derived IL-10 Supports Host Survival during Sepsis

Isaac J. Jensen et al.

Summary: NK cells play a critical role in host survival during sepsis by limiting the scope and duration of the cytokine storm, with NK cell-derived IL-10 being crucial for survival in septic patients. This demonstrates the beneficial regulatory mechanisms of NK cells in controlling systemic inflammation during dysregulated infection-induced inflammatory responses.

JOURNAL OF IMMUNOLOGY (2021)

Add to Collection

Article Virology

Successful Direct Acting Antiviral Therapy in Chronic Hepatitis C Normalizes IFNγ and IL2 Production in T Cells Together with TLR8 Expression and Functionality in Peripheral Blood Mononuclear Cells

Maria Teresa Arias-Loste et al.

Summary: Chronic hepatitis C patients treated with direct acting antivirals (DAA) showed recovery in cell-mediated immune response and TLR8 expression and functionality post-treatment. Additionally, DAA treatment significantly decreased the expression and activation of TLR8 in PBMCs, leading to a reduction in Th1 response levels.

VIRUSES-BASEL (2021)

Add to Collection

Review Immunology

IL-10-Producing ILCs: Molecular Mechanisms and Disease Relevance

Hui Sun et al.

Summary: This study focuses on the production mechanisms of IL-10 in ILCs, the key role of IL-10 in NK and ILC2 cells, and the potential impact of IL-10-producing ILCs in diseases such as infections, allergies, and cancers.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Serum HBV pregenomic RNA exhibited opposite associations with NKdim and NKbright cell immunity in treatment-naïve chronic hepatitis B patients

Yurong Gu et al.

BIOSCIENCE REPORTS (2021)

Add to Collection

Article Immunology

Follicular Helper T (T-FH) Cell Targeting by TLR8 Signaling For Improving HBsAg-Specific B Cell Response In Chronic Hepatitis B Patients

Natarajan Ayithan et al.

Summary: TLR8 activation enhances follicular helper T cell function, leading to improved B cell response in chronic hepatitis B infection. TLR8 agonists may promote monocyte-mediated T-FH function and enhance HBV-specific B cell responses, potentially playing a role in achieving HBV functional cure.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Sensing of HIV-1 by TLR8 activates human T cells and reverses latency

Hany Zekaria Meas et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Review Immunology

Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy

Ji-Yoon Noh et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2020)

Add to Collection

Article Gastroenterology & Hepatology

WHO Guidelines for Prevention, Care and Treatment of Individuals Infected with HBV A US Perspective

Anusha Vittal et al.

CLINICS IN LIVER DISEASE (2019)

Add to Collection

Review Biochemistry & Molecular Biology

The Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV Therapy

Paola Fisicaro et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Add to Collection

Article Immunology

Natural Killer Cell-Derived IL-10 Prevents Liver Damage During Sustained Murine Cytomegalovirus Infection

Alaa Kassim Ali et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Immunology

Human TLR8 Senses RNA From Plasmodium falciparum-Infected Red Blood Cells Which Is Uniquely Required for the IFN-γ Response in NK Cells

Christoph Coch et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection

Haijun Li et al.

GUT (2018)

Add to Collection

Article Immunology

BAFF augments IgA2 and IL-10 production by TLR7/8 stimulated total peripheral blood Bcells

Gerco den Hartog et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study

Peng Hu et al.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Impaired expression and function of TLR8 in chronic HBV infection and its association with treatment responses during peg-IFN-α-2a antiviral therapy

Guangying Deng et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)

Add to Collection

Article Microbiology

Bacterial Manipulation of NK Cell Regulatory Activity Increases Susceptibility to Listeria monocytogenes Infection

Sarah E. Clark et al.

PLOS PATHOGENS (2016)

Add to Collection

Article Multidisciplinary Sciences

HCV RNA Activates APCs via TLR7/TLR8 While Virus Selectively Stimulates Macrophages Without Inducing Antiviral Responses

Yuwei Zhang et al.

SCIENTIFIC REPORTS (2016)

Add to Collection

Article Cell Biology

Roles of Toll-like Receptor 7 and 8 in Prevention of Intrauterine Transmission of Hepatitis B Virus

Ting Tian et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)

Add to Collection

Article Immunology

The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus

Seiichi Sato et al.

IMMUNITY (2015)

Add to Collection

Article Immunology

Natural Killer Cell Characteristics in Patients With Chronic Hepatitis B Virus (HBV) Infection Are Associated With HBV Surface Antigen Clearance After Combination Treatment With Pegylated Interferon Alfa-2a and Adefovir

Femke Stelma et al.

JOURNAL OF INFECTIOUS DISEASES (2015)

Add to Collection

Article Microbiology

Toll-Like Receptor 8 Agonist and Bacteria Trigger Potent Activation of Innate Immune Cells in Human Liver

Juandy Jo et al.

PLOS PATHOGENS (2014)

Add to Collection

Review Immunology

The role of natural killer cells and CD8+ T cells in hepatitis B virus infection

Anita Schuch et al.

FRONTIERS IN IMMUNOLOGY (2014)

Add to Collection

Article Surgery

Toll-Like Receptor 3 and 7/8 Function Is Impaired in Hepatitis C Rapid Fibrosis Progression Post-Liver Transplantation

J. Howell et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2013)

Add to Collection

Article Multidisciplinary Sciences

Sex Differences in the Response to Viral Infections: TLR8 and TLR9 Ligand Stimulation Induce Higher IL10 Production in Males

Maria Gabriella Torcia et al.

PLOS ONE (2012)

Add to Collection

Article Multidisciplinary Sciences

Natural Killer Cells Are Characterized by the Concomitantly Increased Interferon-γ and Cytotoxicity in Acute Resolved Hepatitis B Patients

Juanjuan Zhao et al.

PLOS ONE (2012)

Add to Collection

Article Gastroenterology & Hepatology

Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B

Eric T. T. L. Tjwa et al.

JOURNAL OF HEPATOLOGY (2011)

Add to Collection

Article Microbiology

Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection

Dimitra Peppa et al.

PLOS PATHOGENS (2010)

Add to Collection

Article Immunology

Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists

Kevin S. Gorski et al.

INTERNATIONAL IMMUNOLOGY (2006)

Add to Collection

Article Immunology

TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-γ production

OM Hart et al.

JOURNAL OF IMMUNOLOGY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.